Identification of genes involved in Alzheimer's disease using Drosophila melanogaster

   
   

Transgenic flies displaying altered phenotypes due to expression of the Abeta and C99 portions of the human APP gene are disclosed. Use of these flies in a method to identify Drosophila genes and the human homologs of these Drosophila genes, that are potentially involved in Alzheimer's Disease, is also disclosed. The use of said human homologs as drug targets for the development of therapeutics to treat Alzheimer's Disease and other conditions associated with defects in the APP pathway, as well as pharmaceutical compositions comprising substances directed to these genes, are also disclosed.

 
Web www.patentalert.com

< Anti-backout arthroscopic uni-compartmental prosthesis

< Methods and devices for maintaining patency of surgically created channels in a body organ

> Identification and characterization of a novel alpha-amylase from maize endosperm

> Spinal mobility preservation apparatus having an expandable membrane

~ 00188